NRG-DT001: A PHASE IB TRIAL OF NEOADJUVANT AMG 232 CONCURRENT WITH PREOPERATIVE RADIOTHERAPY IN WILD-TYPE P53 SOFT TISSUE SARCOMA (STS)
This Study is
No Longer Enrolling
Details
Age
Adult
Phase
I - Research Studies that focus on the safety of a drug. The goal is to determine the drug's most frequent and serious adverse events and, often, how the drug is broken down and excreted by the body. These studies usually involve a small number of participants.
Type of Study
Treatment
Locations
Greeley Hospital
Harmony Campus
Longs Peak Hospital
Medical Center of the Rockies
Poudre Valley Hospital
University of Colorado Hospital
Study ID
Protocol Number: 18-1477
More information available at ClinicalTrials.gov: NCT03217266
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers